A carregar...

CTD与PCD方案治疗新诊断多发性骨髓瘤患者的疗效、预后及安全性分析

OBJECTIVE: To observe the efficacy and safety of CTD (cyclophosphamide, thalidomide, dexamethasone) and PCD (bortezomib, cyclophosphamide, dexamethasone) regimens in treatment of patients with newly diagnosed multiple myeloma (NDMM). METHODS: A retrospective analysis was carried out on 88 cases of N...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Zhonghua Xue Ye Xue Za Zhi
Formato: Artigo
Idioma:Inglês
Publicado em: Editorial office of Chinese Journal of Hematology 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342733/
https://ncbi.nlm.nih.gov/pubmed/28468087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.04.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!